QFITLIA Trademark
Trademark Overview
On Thursday, June 22, 2023, a trademark application was filed for QFITLIA with the United States Patent and Trademark Office. The USPTO has given the QFITLIA trademark a serial number of 98054571. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, June 4, 2024. This trademark is owned by Genzyme Corporation. The QFITLIA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare blood disorders; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections; pharmaceutical preparations for the treatment of lysosomal storage diseases
General Information
| Serial Number | 98054571 |
| Word Mark | QFITLIA |
| Filing Date | Thursday, June 22, 2023 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, June 4, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, April 2, 2024 |
Trademark Statements
| Description of Mark | The mark consists of the stylized word "QFITLIA" in dark blue with a yellow circle above the first letter "I," and a row of stylized yellow circles over and extending past the letters "IA". |
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare blood disorders; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections; pharmaceutical preparations for the treatment of lysosomal storage diseases |
| Indication of Colors claimed | The color(s) dark blue and yellow is/are claimed as a feature of the mark. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 25, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Genzyme Corporation |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02141 |
| Party Name | Genzyme Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02141 |
Trademark Events
| Event Date | Event Description |
| Monday, June 26, 2023 | NEW APPLICATION ENTERED |
| Wednesday, July 12, 2023 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Tuesday, July 25, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, July 26, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, December 12, 2023 | ASSIGNED TO LIE |
| Tuesday, December 12, 2023 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| Monday, February 12, 2024 | ASSIGNED TO EXAMINER |
| Thursday, February 22, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 13, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 2, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 2, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 4, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, November 18, 2024 | SOU TEAS EXTENSION RECEIVED |
